title: Sphingolipids function as downstream effectors of a fungal PAQR.
abstract: The Izh2p protein from Saccharomyces cerevisiae belongs to the newly characterized progestin and adipoQ receptor (PAQR) superfamily of receptors whose mechanism of signal transduction is still unknown. Izh2p functions as a receptor for the plant PR-5 defensin osmotin and has pleiotropic effects on cellular biochemistry. One example of this pleiotropy is the Izh2p-dependent repression of FET3, a gene involved in iron-uptake. Although the physiological purpose of FET3 repression by Izh2p is a matter of speculation, it provides a reporter with which to probe the mechanism of signal transduction by this novel class of receptor. Receptors in the PAQR family share sequence similarity with enzymes involved in ceramide metabolism, which led to the hypothesis that sphingolipids are involved in Izh2p-dependent signaling. In this study, we demonstrate that drugs affecting sphingolipid metabolism, such as d-erythro-MAPP and myriocin, inhibit the effect of Izh2p on FET3. We also show that Izh2p causes an increase in steady-state levels of sphingoid base. Moreover, we show that Izh2p-independent increases in sphingoid bases recapitulate the effect of Izh2p on FET3. Finally, our data indicate that the Pkh1p and Pkh2p sphingoid base-sensing kinases are essential components of the Izh2p-dependent signaling pathway. In conclusion, our data indicate that Izh2p produces sphingoid bases and that these bioactive lipids probably function as the second messenger responsible for the effect of Izh2p on FET3.
authors.affiliation: Department of Chemistry, University of Florida, Gainesville, FL 32611, USA.
authors.forename: Nancy Y
authors.initials: NY
authors.lastname: Villa
authors.forename: Brian R
authors.initials: BR
authors.lastname: Kupchak
authors.forename: Ibon
authors.initials: I
authors.lastname: Garitaonandia
authors.forename: Jessica L
authors.initials: JL
authors.lastname: Smith
authors.forename: Emilio
authors.initials: E
authors.lastname: Alonso
authors.forename: Charlene
authors.initials: C
authors.lastname: Alford
authors.forename: L Ashley
authors.initials: LA
authors.lastname: Cowart
authors.forename: Yusuf A
authors.initials: YA
authors.lastname: Hannun
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Lyons
mesh_terms: D002518:Ceramides / Q000096:biosynthesis / Q000737:chemistry / Q000502:physiology; D002570:Ceruloplasmin / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology; D008565:Membrane Proteins / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D008957:Models, Genetic; D029701:Saccharomyces cerevisiae Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D015290:Second Messenger Systems / Q000235:genetics / Q000502:physiology*; D013107:Sphingolipids / Q000737:chemistry / Q000378:metabolism / Q000502:physiology*
chemical_list: D002518:Ceramides; C497767:IZH2 protein, S cerevisiae; D008565:Membrane Proteins; D029701:Saccharomyces cerevisiae Proteins; D013107:Sphingolipids; D002570:Ceruloplasmin; C085513:FET3 protein, S cerevisiae